Sudan Malignant Pleural Mesothelioma Market (2025-2031) | Outlook, Analysis, Growth, Segmentation, Share, Competitive Landscape, Value, Industry, Trends, Companies, Size & Revenue, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Sudan Country Macro Economic Indicators

3.2 Sudan Malignant Pleural Mesothelioma Market Revenues & Volume, 2021 & 2031F

3.3 Sudan Malignant Pleural Mesothelioma Market - Industry Life Cycle

3.4 Sudan Malignant Pleural Mesothelioma Market - Porter's Five Forces

3.5 Sudan Malignant Pleural Mesothelioma Market Revenues & Volume Share, By Drugs, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about the risks of asbestos exposure in Sudan

4.2.2 Growth in healthcare infrastructure and access to diagnostic facilities in the country

4.2.3 Rising prevalence of malignant pleural mesothelioma cases in Sudan

4.3 Market Restraints

4.3.1 Limited availability of specialized treatment centers for malignant pleural mesothelioma

4.3.2 Challenges in early diagnosis and detection of the disease

4.3.3 Lack of standardized treatment protocols and guidelines in Sudan

6.1 Sudan Malignant Pleural Mesothelioma Market, By Drugs

6.1.1 Overview and Analysis

6.1.2 Sudan Malignant Pleural Mesothelioma Market Revenues & Volume, By Drugs, 2021- 2031F

6.1.3 Sudan Malignant Pleural Mesothelioma Market Revenues & Volume, By Opdivo (Nivolumab), 2021- 2031F

6.1.4 Sudan Malignant Pleural Mesothelioma Market Revenues & Volume, By Yervoy (Ipilimumab), 2021- 2031F

6.1.5 Sudan Malignant Pleural Mesothelioma Market Revenues & Volume, By MTG201, 2021- 2031F

6.1.6 Sudan Malignant Pleural Mesothelioma Market Revenues & Volume, By CBP501, 2021- 2031F

6.1.7 Sudan Malignant Pleural Mesothelioma Market Revenues & Volume, By Lurbinectedin, 2021- 2031F

7.1 Sudan Malignant Pleural Mesothelioma Market Export to Major Countries

7.2 Sudan Malignant Pleural Mesothelioma Market Imports from Major Countries

8.1 Average time from diagnosis to treatment initiation for malignant pleural mesothelioma patients

8.2 Percentage increase in funding for mesothelioma research and awareness campaigns

8.3 Number of healthcare professionals trained in diagnosing and treating malignant pleural mesothelioma

9.1 Sudan Malignant Pleural Mesothelioma Market Opportunity Assessment, By Drugs, 2021 & 2031F

10.1 Sudan Malignant Pleural Mesothelioma Market Revenue Share, By Companies, 2024

10.2 Sudan Malignant Pleural Mesothelioma Market Competitive Benchmarking, By Operating and Technical Parameters